Bis -Allylic Deuterated Docosahexaenoic Acid-Esterified Phospholipids Resist In Vivo Peroxidation in Rat Brain
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.4c17871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Secilia Garza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Texas at Austin, Austin, Texas 78705, United States. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Phospholipids, Brain, Lipid Peroxidation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BioJiva LLC.
Abstract (Originalsprache)
The human central nervous system simultaneously has the most highly unsaturated fatty acids (HUFAs) and the highest metabolic rate among body tissue. Up to 1% of consumed O2 is converted to reactive oxygen species (ROS) that cause unregulated damage to HUFA-rich membrane phospholipids (PLs). Docosahexaenoic acid (DHA) is the brain's most unsaturated and abundant HUFA. Reinforcing the ROS-labile bis-allylic positions with deuterium (D-DHA) protects against oxidative damage in vitro and in vivo. We developed an LC-MS/MS method to detect ambient levels of nascent oxidation products of DHA and D-DHA containing PLs in vivo in rat brain lipid extracts. Multiple reaction monitoring (MRM)-triggered mass spectra confirmed D-DHA incorporation in D-DHA-fed rat brain PLs. DHA-PL nascent oxidation products add 2 O, consistent with known peroxidation reactions. In contrast, D-DHA oxidation is primarily detected as a single O addition, consistent with epoxidation. D-DHA-PL showed 20%-30% lower overall oxidation compared to DHA-PL. Our data are consistent with a mechanism of action whereby D-DHA blocks excess lipid peroxidation, leading to lower overall membrane damage. D-DHA is a unique therapeutic approach against neurodegenerative diseases where ROS-driven oxidation is implicated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Texas at Austin, Austin, Texas 78705, United States.
- Dell Pediatric Research Institute, Department of Pediatrics, University of Texas at Austin, Austin, Texas 78723, United States.
- SCIEX, Redwood Shores, California 64065, United States.
- Oklahoma Center for Neurosciences, University of Oklahoma Health Sciences Center, Dean McGee Eye Institute, Oklahoma City, Oklahoma 73104, United States.
- Institut des Biomolécules Max Mousseron, Université de Montpellier, CNRS, ENSCM, 34090 Montpellier, France.
- Skolkovo Institute of Science and Technology, Moscow 121205, Russia.
ORCID-Profile: Secilia Garza, Vicki Ea, J Thomas Brenna
Förderung
- BioJiva LLC
Zitieren
APA
Garza, S., James, G., Park, H. G., Baker, P. R. S., Agbaga, M. P., Ea, V., Shchepinov, M. S., & Brenna, J. T. (2025). Bis -Allylic Deuterated Docosahexaenoic Acid-Esterified Phospholipids Resist In Vivo Peroxidation in Rat Brain. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c17871
Vancouver
Garza S, James G, Park HG, Baker PRS, Agbaga MP, Ea V, et al. Bis -Allylic Deuterated Docosahexaenoic Acid-Esterified Phospholipids Resist In Vivo Peroxidation in Rat Brain. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c17871
BibTeX
@article{Garza2025,
author = {Garza, Secilia and James, Genevieve and Park, Hui Gyu and Baker, Paul R S and Agbaga, Martin-Paul and Ea, Vicki and Shchepinov, Mikhail S and Brenna, J Thomas},
title = {Bis -Allylic Deuterated Docosahexaenoic Acid-Esterified Phospholipids Resist In Vivo Peroxidation in Rat Brain},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.4c17871}
}
EUVIMED